John Mitchell
Critical Care Medicine · Charleston, SCNPI 1205886124
Payments from drug & device makers
Across 492 payments — averaging $257.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$96K
- Boehringer Ingelheim$23K
- Jazz Pharmaceuticals Inc.$1K
- GSK$992
- Insmed, Inc.$723
- Axsome Therapeutics, Inc.$527
- plus $4K from 35 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$126,494 in reported general payments places this provider in the 90th percentile of 93 critical care medicine providers in South Carolina.
See all critical care medicine providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Charleston
- Rahul ArgulaCharleston$2.9M
- Charlton StrangeCharleston$1.4M
- Andrew GoodwinCharleston$751K
- James CarswellCharleston$458K
- Jason GunnCharleston$217K
- Tatsiana BeikoCharleston$156K
- Christopher GilbertCharleston$106K
- Nicholas FoxCharleston$88K
- Gregory SquiresCharleston$14K
- Luca PaolettiCharleston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.